Published in Am J Respir Crit Care Med on June 22, 2016
Improving Psychosocial Well-being in COPD Patients in Rehabilitation (IMPROVE) | NCT03470025
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med (2008) 7.33
Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med (1998) 6.10
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (2009) 5.51
Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med (1995) 2.64
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med (2002) 2.41
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med (2010) 2.40
Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J (2005) 2.23
Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med (2009) 2.21
Exercise capacity and mortality in black and white men. Circulation (2008) 2.17
Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 2.09
Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J (2007) 2.04
Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J (2014) 2.01
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2009) 1.98
The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J (2010) 1.90
Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med (2000) 1.89
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 1.80
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys (2007) 1.70
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. Am J Respir Crit Care Med (2016) 1.53
An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J (2014) 1.44
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax (2008) 1.40
Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2005) 1.39
Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med (1989) 1.35
A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med (2001) 1.35
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med (2010) 1.30
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc (2011) 1.28
Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest (2002) 1.23
Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J (2007) 1.23
Prognostic value of treadmill exercise testing: a population-based study in Olmsted County, Minnesota. Circulation (1999) 1.18
Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med (2007) 1.17
Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol (2012) 1.15
The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J (2006) 1.09
Combining multiple imputation and meta-analysis with individual participant data. Stat Med (2013) 1.07
The COPD Biomarker Qualification Consortium (CBQC). COPD (2013) 1.06
Functional status and survival following pulmonary rehabilitation. Chest (2000) 1.05
Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.03
The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med (2011) 0.87
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J (2016) 0.81
Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev (2015) 0.76